Dupilumab treatment led to significant SCORAD score reductions, with 37% achieving a 75% reduction and 72% reaching mild disease status by week 16. Improvements were observed as early as week 2, with ...

NEW YORK CITY -- An oral drug that targets Th2 activity in atopic dermatitis reduced disease activity by as much as 50% after 6 weeks, results of a small placebo-controlled study showed. At 4 weeks of ...

This study developed an AI model that accurately detects body parts and eczema lesions and objectively assesses eczema severity (TIS score), demonstrating strong correlation with ...

Please provide your email address to receive an email when new articles are posted on . LOUISVILLE, Ky. — Allergen-specific immunotherapy showed efficacy among patients with atopic and contact ...

This review verified past study findings, finding that probiotics can effectively improve atopic dermatitis (AD) in children. The researchers noted that probiotics gained attention for AD treatment ...